Increasing Incidence of Mucormycosis in University Hospital, Belgium
To determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000–2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying h...
Main Authors: | Veroniek Saegeman, Johan Maertens, Wouter Meersseman, Isabel Spriet, Eric Verbeken, Katrien Lagrou |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2010-09-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/16/9/10-0276_article |
Similar Items
-
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
by: Morfín-Otero R, et al.
Published: (2018-09-01) -
The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
by: Ali Atoui, et al.
Published: (2021-10-01) -
Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01) -
Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01) -
Pyrenocheata unguis-hominis: A new cause of fungal keratitis in a contact lens wearer
by: Sima Nissan, et al.
Published: (2022-12-01)